BOSTON, June 20, 2017 /PRNewswire/ — Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Axiom Holdings, Inc. (“Axiom” or the “Company”) (OTCQB: AIOM) and certain of its officers and directors violated federal securities laws.
On June 19, 2017, Axiom disclosed that it had received a subpoena from the Securities and Exchange Commission (“SEC”) apparently regarding the propriety of the Company’s December 2016 share exchange with CJC Holdings, Ltd., under which Axiom acquired all of CJC’s outstanding shares. Specifically, Axiom disclosed the purported CEO of CJC, who signed the share exchange agreement in December 2016, had actually resigned from that role a month earlier.
On this news, Axiom’s stock fell nearly 22%, causing millions in losses to shareholders.
If you purchased or otherwise acquired Axiom securities and have questions about your legal rights or possess information relevant to this investigation, please contact attorney Bradley Vettraino at (617) 398-5600, by email at bradley@blockesq.com, or by visiting www.blockesq.com/axiom.   
Confidentiality to whistleblowers or others with information relevant to this investigation is assured.
Block & Leviton LLP is a Boston-based law firm representing investors nationwide. The firm’s lawyers have collectively been prosecuting securities cases on behalf of individual and institutional investors for over 50 years, and have recovered billions of dollars on their behalf. Block & Leviton’s investigations into corporate wrongdoing were recently covered by the New York Times.
This notice may constitute attorney advertising.
CONTACT:Block & Leviton LLPBradley J. Vettraino155 Federal Street, Suite 400Boston, MA 02110(617) 398-5600bradley@blockesq.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/axiom-holdings-inc-aiom-investigated-for-securities-fraud-by-block–leviton-after-disclosing-an-sec-investigation-300476703.html
SOURCE Block & Leviton LLP
Copyright © 2017 PR Newswire. All Rights ReservedThe above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Related Posts Plugin for WordPress, Blogger...